Skip to main content
Clinical Trials/NL-OMON39532
NL-OMON39532
Completed
Not Applicable

Immune ageing in health and disease - Immune ageing in health and disease

niversitair Medisch Centrum Groningen0 sites300 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
gezonde veroudering en ongezonde veroudering/frailty
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
300
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Group 1: Healthy young donors
  • 1\. Having no chronic diseases
  • 2\. Healthy according to SENIEUR protocol
  • 3\. Not\-frail according to frailty instruments (Fried)
  • 4\. Age 19\-39 years
  • 5\. Being able to give informed consent;Group 2: Healthy intermediate\-age donors
  • 1\. Having no chronic diseases
  • 2\. Healthy according to SENIEUR protocol
  • 3\. Not\-frail according to frailty instruments (Fried)
  • 4\. Age 40\-60 years

Exclusion Criteria

  • In general:
  • 1\. No informed consent
  • 2\. Clinical signs of severe anaemia, or persons known to have anaemia defined as a hemoglobulin level of less than 6,0 g/dL
  • 3\. Pregnancy;Non\-SENIEUR elderly donors
  • 1\. Disease that has been reported to influence the immune system (active infection, inflammatory disease, malignancy, dementia, alcohol or drug abuse)
  • 2\. Drugs that have been reported to influence the immune system (corticosteroids, other immuno suppressive therapy, vaccination in prior 4 weeks)

Outcomes

Primary Outcomes

Not specified

Similar Trials